Arrowhead Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/10/2026 | 1,049 | 0.0% | 15,802 | 12/31/2025 |
| 2025 Q3 | 10/31/2025 | 534 | 0.0% | 15,487 | 9/30/2025 |
| 2025 Q2 | 7/29/2025 | 255 | 0.0% | 16,144 | 6/30/2025 |
| 2025 Q1 | 5/9/2025 | 234 | 0.0% | 18,363 | 3/31/2025 |
| 2024 Q4 | 2/5/2025 | 1,235 | 0.0% | 65,668 | 12/31/2024 |
| 2024 Q3 | 11/6/2024 | 1,301 | 0.0% | 67,187 | 9/30/2024 |
| 2024 Q2 | 8/9/2024 | 1,848 | 0.0% | 71,111 | 6/30/2024 |
| 2024 Q1 | 5/2/2024 | 2,111 | 0.0% | 73,826 | 3/31/2024 |
| 2023 Q4 | 1/26/2024 | 2,027 | 0.0% | 66,229 | 12/31/2023 |
| 2023 Q3 | 11/9/2023 | 3,040 | 0.0% | 113,132 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 4,428 | 0.1% | 124,175 | 6/30/2023 |
| 2023 Q1 | 5/4/2023 | 3,472 | 0.0% | 136,677 | 3/31/2023 |
| 2022 Q4 | 2/10/2023 | 5,630 | 0.1% | 138,804 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 4,501 | 0.1% | 136,195 | 9/30/2022 |
| 2022 Q2 | 8/10/2022 | 4,725 | 0.1% | 134,205 | 6/30/2022 |
| 2022 Q1 | 5/2/2022 | 6,546 | 0.1% | 142,328 | 3/31/2022 |
| 2021 Q4 | 2/3/2022 | 9,375 | 0.1% | 141,403 | 12/31/2021 |
| 2021 Q3 | 11/10/2021 | 8,773 | 0.1% | 140,520 | 9/30/2021 |
| 2021 Q2 | 8/6/2021 | 11,546 | 0.1% | 139,409 | 6/30/2021 |
| 2021 Q1 | 5/13/2021 | 11,183 | 0.1% | 168,640 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 13,383 | 0.2% | 174,414 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 7,707 | 0.1% | 178,973 | 9/30/2020 |
| 2020 Q2 | 8/6/2020 | 5,544 | 0.1% | 128,363 | 6/30/2020 |
| 2020 Q1 | 5/11/2020 | 4,149 | 0.1% | 144,212 | 3/31/2020 |
| 2019 Q4 | 2/11/2020 | 9,035 | 0.1% | 142,442 | 12/31/2019 |